192 related articles for article (PubMed ID: 33974715)
1. Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030.
Wu J; Xiao F; Zheng Y; Lin Y; Wang HL
Cancer; 2021 Sep; 127(17):3172-3182. PubMed ID: 33974715
[TBL] [Abstract][Full Text] [Related]
2. Sex Differences in Time Trends on Incidence Rates of Oropharyngeal and Oral Cavity Cancers in Hong Kong.
Chan MH; Wang F; Mang WK; Tse LA
Ann Otol Rhinol Laryngol; 2018 Dec; 127(12):895-902. PubMed ID: 30269509
[TBL] [Abstract][Full Text] [Related]
3. Global burden of oropharyngeal cancer attributable to human papillomavirus by anatomical subsite and geographic region.
Lu Y; Xie Z; Luo G; Yan H; Qian HZ; Fu L; Wang B; Huang R; Cao F; Lin H; You R; Tan L; Yu T; Chen M; Li C; Liu X; Lei W; Zou H
Cancer Epidemiol; 2022 Jun; 78():102140. PubMed ID: 35303618
[TBL] [Abstract][Full Text] [Related]
4. Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007-2030.
Duan R; Xu K; Huang L; Yuan M; Wang H; Qiao Y; Zhao F
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):1130-1136. PubMed ID: 35266990
[TBL] [Abstract][Full Text] [Related]
5. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
[TBL] [Abstract][Full Text] [Related]
6. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.
Chaturvedi AK; Anderson WF; Lortet-Tieulent J; Curado MP; Ferlay J; Franceschi S; Rosenberg PS; Bray F; Gillison ML
J Clin Oncol; 2013 Dec; 31(36):4550-9. PubMed ID: 24248688
[TBL] [Abstract][Full Text] [Related]
7. Cancer attributable to human papillomavirus infection in China: Burden and trends.
Lu Y; Li P; Luo G; Liu D; Zou H
Cancer; 2020 Aug; 126(16):3719-3732. PubMed ID: 32484937
[TBL] [Abstract][Full Text] [Related]
8. International trends in esophageal cancer incidence rates by histological subtype (1990-2012) and prediction of the rates to 2030.
Lin Y; Wang HL; Fang K; Zheng Y; Wu J
Esophagus; 2022 Oct; 19(4):560-568. PubMed ID: 35689719
[TBL] [Abstract][Full Text] [Related]
9. Trends in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma Incidence, Vermont 1999-2013.
Owosho AA; Wiley R; Stansbury T; Gbadamosi SO; Ryder JS
J Community Health; 2018 Aug; 43(4):731-737. PubMed ID: 29427129
[TBL] [Abstract][Full Text] [Related]
10. Prevention and Screening of HPV Malignancies.
Dahlstrom KR; Day AT; Sturgis EM
Semin Radiat Oncol; 2021 Oct; 31(4):297-308. PubMed ID: 34455985
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic burden of HPV-related cancers in the US veteran population.
Saxena K; Dawson RS; Cyhaniuk A; Bello T; Janjan N
J Med Econ; 2022; 25(1):299-308. PubMed ID: 35156867
[TBL] [Abstract][Full Text] [Related]
12. Age-group-specific trend analyses of oropharyngeal squamous cell carcinoma incidence from 1989 to 2018 and risk factors profile by age-group in 2015-2018: a population-based study in The Netherlands.
Al-Jamaei AAH; Helder MN; Forouzanfar T; Brakenhoff RH; Leemans CR; de Visscher JGAM; van Dijk BAC
Eur J Cancer Prev; 2022 Mar; 31(2):158-165. PubMed ID: 34267108
[TBL] [Abstract][Full Text] [Related]
13. Trends in incidence rates of head and neck squamous cell carcinomas overall and by potential relatedness to human papillomavirus, Costa Rica 2006 to 2015.
Carvajal LJ; Shing JZ; Vanegas JC; González E; Guillén D; Sierra MS; Hildesheim A; Porras C; Herrero R; Torres G; Shiels MS; Calderón A; Kreimer AR
Int J Cancer; 2023 May; 152(10):2052-2060. PubMed ID: 36650690
[TBL] [Abstract][Full Text] [Related]
14. Projected Association of Human Papillomavirus Vaccination With Oropharynx Cancer Incidence in the US, 2020-2045.
Zhang Y; Fakhry C; D'Souza G
JAMA Oncol; 2021 Oct; 7(10):e212907. PubMed ID: 34473210
[TBL] [Abstract][Full Text] [Related]
15. [Knowledge of Dutch dentists regarding HPV associated cancer of the oropharynx].
Poelman MR; Brand HS; de Visscher JGAM; Jager DHJ
Ned Tijdschr Tandheelkd; 2021 Nov; 128(11):557-563. PubMed ID: 34747166
[TBL] [Abstract][Full Text] [Related]
16. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
Forte T; Niu J; Lockwood GA; Bryant HE
Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
[TBL] [Abstract][Full Text] [Related]
17. [Infection of human papillomavirus and head and neck cancer].
Song C; Zhang SK; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):39-43. PubMed ID: 36709118
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe.
Mena M; Frias-Gomez J; Taberna M; Quirós B; Marquez S; Clavero O; Baena A; Lloveras B; Alejo M; León X; García J; Mesía R; Bermejo O; Bonfill T; Aguila A; Guix M; Hijano R; Pavón MA; Torres M; Tous S; Clèries R; Alemany L
Sci Rep; 2020 Aug; 10(1):13219. PubMed ID: 32764593
[TBL] [Abstract][Full Text] [Related]
19. Increasing Incidence rates of Oropharyngeal Squamous Cell Carcinoma in Germany and Significance of Disease Burden Attributed to Human Papillomavirus.
Wittekindt C; Wagner S; Bushnak A; Prigge ES; von Knebel Doeberitz M; Würdemann N; Bernhardt K; Pons-Kühnemann J; Maulbecker-Armstrong C; Klussmann JP
Cancer Prev Res (Phila); 2019 Jun; 12(6):375-382. PubMed ID: 31003993
[TBL] [Abstract][Full Text] [Related]
20. Is 2045 the best we can do? Mitigating the HPV-related oropharyngeal cancer epidemic.
Schuman A; Anderson KS; Day AT; Ferrell J; Sturgis EM; Dahlstrom KR
Expert Rev Anticancer Ther; 2022 Jul; 22(7):751-761. PubMed ID: 35679626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
